Cargando…
Cerebrospinal Fluid TNF-α and Orexin in Patients With Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder
BACKGROUND: Parkinson's disease (PD) pathological changes begin before motor symptoms appear. Rapid eye movement sleep behavior disorder (RBD) has the highest specificity and predictive value of any marker of prodromal PD. Tumor necrosis factor α (TNF-α) plays a part in the pathology of PD and...
Autores principales: | Yuan, Yuan, Zhang, Yimeng, Cheng, Yueyang, Hou, Yue, Huang, Zhaoyang, Ma, Jinghong, Li, Ning, Zhan, Shuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894667/ https://www.ncbi.nlm.nih.gov/pubmed/35250828 http://dx.doi.org/10.3389/fneur.2022.826013 |
Ejemplares similares
-
The Relationship of Rapid Eye Movement Sleep Behavior Disorder and Freezing of Gait in Parkinson’s Disease
por: Nobleza, Chelsea Mae N, et al.
Publicado: (2020) -
Quantitative sleep electroencephalogram and cognitive performance in Parkinson’s disease with and without rapid eye movement sleep behavior disorder
por: Memon, Adeel A., et al.
Publicado: (2023) -
Altered Brain Functional Network in Parkinson Disease With Rapid Eye Movement Sleep Behavior Disorder
por: Li, Jiao, et al.
Publicado: (2020) -
Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder
por: Long, Kexin, et al.
Publicado: (2020) -
The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
por: Tao, Mingzhu, et al.
Publicado: (2022)